Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Март 14, 2025
Analyses
of
patient-derived
cell
lines
have
greatly
enhanced
discovery
molecular
biomarkers
and
therapeutic
targets.
However,
characterization
cellular
morphological
properties
is
limited.
We
studied
morphologies
human
pancreatic
adenocarcinoma
(PDAC)
their
associations
with
drug
sensitivity,
gene
expression,
functional
properties.
By
integrating
live
spatial
mRNA
imaging,
we
identified
KRAS
inhibitor-induced
changes
specific
for
drug-resistant
cells
that
correlated
expression
changes.
then
categorized
a
large
panel
PDAC
into
(e.g.,
polygonal,
irregular,
spheroid)
organizational
tightly
aggregated,
multilayered,
dispersed)
subtypes
found
differences
in
targeting
potential,
metastatic
proclivity.
In
tissues,
prognostic
signatures
associated
distinct
cancer
organization
patterns.
summary,
highlight
the
potential
information
rapid,
cost-effective
assays
to
aid
precision
oncology
efforts
leveraging
vitro
models
tissues.
Язык: Английский
Unifying Genetic and Chemical Perturbagen Representation through a Hybrid Deep Learning Framework
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 7, 2025
The
integration
of
genetic
and
chemical
perturbations
has
driven
transformative
advances
in
elucidating
cellular
mechanisms
accelerating
drug
discovery.
However,
the
lack
a
unified
representation
for
diverse
perturbagen
types
limits
comprehensive
analysis
joint
modeling
multi-domain
perturbation
agents
(molecular
cause
space)
their
resulting
phenotypes
(phenotypic
effect
spaces).
Here,
we
present
UniPert,
hybrid
deep
learning
framework
that
encodes
perturbagens
into
shared
semantic
space.
UniPert
employs
tailored
encoders
to
address
inherent
molecular-scale
differences
across
leverages
contrastive
with
experiment-driven
compound-target
interactions
bridge
these
domains.
Extensive
experiments
validate
UniPert’s
versatility
application.
generated
representations
effectively
capture
hierarchical
pharmacological
relationships
perturbagens,
facilitating
annotations
understudied
targets
compounds.
can
be
plugged
advanced
frameworks
enhance
performance
both
outcome
prediction
tasks.
Notably,
paves
way
cross-domain
modeling,
driving
novel
genetic-to-chemical
transfer
paradigm,
boosting
context-specific
silico
screening
efficiency
development
personalized
therapies.
Язык: Английский
A Framework for Autonomous AI-Driven Drug Discovery
Douglas W. Selinger,
Tom Wall,
Eleni Stylianou
и другие.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 20, 2024
Abstract
The
exponential
increase
in
biomedical
data
offers
unprecedented
opportunities
for
drug
discovery,
yet
overwhelms
traditional
analysis
methods,
limiting
the
pace
of
new
development.
Here
we
introduce
a
framework
autonomous
artificial
intelligence
(AI)-driven
discovery
that
integrates
knowledge
graphs
with
large
language
models
(LLMs).
It
is
capable
planning
and
carrying
out
automated
programs
while
providing
details
its
research
strategy,
progress,
supporting
points,
enabling
thorough
assessment
methods
findings.
At
heart
this
lies
“focal
graph”
-
novel
construct
harnesses
centrality
algorithms
to
distill
vast,
noisy
datasets
into
concise,
transparent,
data-driven
hypotheses.
By
high-throughput
search
result
interpretation,
such
could
be
used
execute
massive
numbers
searches,
identify
patterns
across
complex,
diverse
datasets,
prioritize
actionable
hypotheses
at
scale
speed
unachievable
by
human
researchers
alone.
We
demonstrate
even
small-
applications
approach
can
yield
novel,
transparent
insights
relevant
multiple
stages
process
present
prototype
system
autonomously
executing
multi-step
target
workflow.
focal
graph
described
here,
automation
it
enables,
represents
promising
path
forward:
towards
deeper
understanding
mechanisms
underlying
disease
true
acceleration
development
therapeutics.
Graphical
Язык: Английский